Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The Taiwan site entry with postal code 333 was updated to Taoyuan City, Taiwan, 333. The previous Taoyuan, Taiwan, 333 entry was removed and replaced with the Taoyuan City variant to reflect the corrected city designation.
    Difference
    0.0%
    Check dated 2026-05-08T11:55:28.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was incremented from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T06:15:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:43:28.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:16:02.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and deleted Revision: v3.4.2 in the page’s version history. This is a minor update that does not modify the study content or results.
    Difference
    0.1%
    Check dated 2026-03-12T01:03:38.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new site in Ciudad de Buenos Aires, Argentina (C1120AAT) was added on 2026-02-27, and the Buenos Aires, Argentina site was removed on 2025-10-28.
    Difference
    0.3%
    Check dated 2026-03-04T23:47:48.000Z thumbnail image

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.